Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Dyne Therapeutics Inc’s stock clocked out at $12.25, down -0.65% from its previous closing price of $12.33. In other words, the price has decreased by -$0.65 from its previous closing price. On the day, 2.79 million shares were traded. DYN stock price reached its highest trading level at $12.42 during the session, while it also had its lowest trading level at $12.05.
Ratios:
To gain a deeper understanding of DYN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.83 and its Current Ratio is at 16.83. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Bernstein on June 24, 2025, initiated with a Mkt Perform rating and assigned the stock a target price of $13.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 14 ’25 when Cox John bought 100,000 shares for $9.11 per share. The transaction valued at 911,000 led to the insider holds 242,179 shares of the business.
Scalzo Richard William bought 1,330 shares of DYN for $19,619 on Jun 11 ’25. On Jun 11 ’25, another insider, Beskrovnaya Oxana, who serves as the Officer of the company, bought 2,132 shares for $14.75 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 1742733952 and an Enterprise Value of 1179882752.
Stock Price History:
The Beta on a monthly basis for DYN is 1.09, which has changed by -0.7395834 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, DYN has reached a high of $47.45, while it has fallen to a 52-week low of $6.36. The 50-Day Moving Average of the stock is 16.12%, while the 200-Day Moving Average is calculated to be -20.68%.
Shares Statistics:
It appears that DYN traded 2.90M shares on average per day over the past three months and 3687300 shares per day over the past ten days. A total of 114.34M shares are outstanding, with a floating share count of 109.94M. Insiders hold about 22.72% of the company’s shares, while institutions hold 71.75% stake in the company. Shares short for DYN as of 1753920000 were 16306402 with a Short Ratio of 5.63, compared to 1751241600 on 16372165. Therefore, it implies a Short% of Shares Outstanding of 16306402 and a Short% of Float of 12.8.
Earnings Estimates
Its stock is currently analyzed by 12.0 different market analysts. The consensus estimate for the next quarter is -$0.85, with high estimates of -$0.64 and low estimates of -$1.2.
Analysts are recommending an EPS of between -$3.21 and -$4.37 for the fiscal current year, implying an average EPS of -$3.67. EPS for the following year is -$3.53, with 14.0 analysts recommending between -$2.81 and -$4.95.
